No Data
Novavax, Inc. (NASDAQ:NVAX) Shares Could Be 45% Below Their Intrinsic Value Estimate
Express News | Novavax Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Revenue Results
Novavax Call Volume Above Normal and Directionally Bullish
U.S. stocks move | Novavax (NVAX.US) rises nearly 10% as BTIG initiates a "Buy" rating.
As of the time of writing, the stock has risen nearly 10%, priced at $7.765.
H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
BofA Securities Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $12
